Bone marrow cells in the 'pre-metastatic niche': Within bone and beyond

Cancer and Metastasis Reviews

Volumn 25, Issue 4, 2006, Pages 521-529

  Kaplan, Rosandra N ^a   Psaila, Bethan ^a   Lyden, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bone marrow derived progenitors; Cancer metastasis; Osteoblasts; Osteoclasts; PIGF; Tumor microenvironment; VEGF Receptor 1

Indexed keywords

CYTOKINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

BONE MARROW CELL; BONE MARROW METASTASIS; BREAST CARCINOMA; CANCER RESEARCH; CARCINOGENESIS; COLON CARCINOMA; HEMATOPOIETIC CELL; HUMAN; LIVER METASTASIS; LUNG CARCINOMA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; TUMOR CELL;

ANIMALS; BONE MARROW CELLS; BONE NEOPLASMS; CYTOKINES; DISEASE PROGRESSION; HEMATOPOIESIS; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846044750     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-9036-9     Document Type: Review

References (75)

1. Weigelt, B., Peterse, J. L., & van 't Veer, L. J. (2005). Breast cancer metastasis: Markers and models. Nature Reviews. Cancer, 5, 591-602.
2. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438, 820-827.
3. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563-572.
4. Fidler, I. J. (1970). Metastasis: Quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45, 773-782.
5. Fidler, I. J., & Nicolson, G. L. (1977). Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. Journal of the National Cancer Institute, 58, 1867-1872.
6. Liotta, L. A., Vembu, D., Saini, R. K., & Boone, C. (1978). In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. Cancer Research, 38, 1231-1236.
7. Varani, J., Lovett, E. J., Elgebaly, S., Lundy, J., & Ward, P. A. (1980). In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. American Journal of Pathology, 101, 345-352.
8. Mehlen, P., & Puisieux, A. (2006). Metastasis: a question of life or death. Nature Reviews. Cancer, 6, 449-458.
9. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine, 347, 1999-2009.
10. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537-549.
11. Kang, Y. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537-549.
12. Lord, B. (1997). Biology of the hematopoietic stem cell. In C. S. Potten (Ed.), Stem cells (pp. 401-422). London: Academic.
13. Nilsson, S. K., Johnston, H. M., & Coverdale, J. A. (2001). Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches. Blood, 97, 2293-2299.
14. Taichman, R. S., & Emerson, S. G. (1998). The role of osteoblasts in the hematopoietic microenvironment. Stem Cells, 16, 7-15.
15. Jin, D. K., Shido, K., Kopp, H. G., Petit, I., Shmelkov, S. V., Young, L. M., et al. (2006). Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 (+) hemangiocytes. Nature Medicine, 12, 557-567.
16. Uchida, S., Sakai, A., Kudo, H., Otomo, H., Watanuki, M., Tanaka, M., et al. (2003). Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone, 32, 491-501.
17. Ratajczak, M. Z., Ratajczak, J., Machalinski, B., Majka, M., Marlicz, W., Carter, A., et al. (1998). Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth. British Journal of Haematology, 103, 969-979.
18. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41-49.
19. Gerber, H., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Medicine, 5, 623-628.
20. Hall, C. L., Kang, S., MacDougald, O. A., & Keller, E. T. (2006). Role of Wnts in prostate cancer bone metastases. Journal of Cellular Biochemistry, 97, 661-672.
21. Kitagawa, Y. K., Dai, J., Zhang, J., Keller, J. M., Nor, J., Yao, Z., et al. (2005). Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Research, 65, 109921-109929.
22. Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C., & Brenner, R. E. (2005). VEGF-A and PlGF stimulate chemotactic migration of human mesenchymal progenitor cells. Biochemical and Biophysical Research Communications, 334, 561-568.
23. List, A. F., Glinsmann-Gibson, B., Stadheim, C., Meuillet, E. J., Bellamy, W., & Powis, G. (2004). Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells. Experimental Hematology, 32, 526-535.
24. Fragoso, R., Pereira, T., Wu, Y., Zhu, Z., Cabecadas, J., & Dias, S. (2006). VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood, 107, 1608-1616.
25. Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., et al. (2006). VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB Journal, 20, 1495-1497.
26. Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670-677.
27. Mendes, S. C., Robin, C., & Dzierzak, E. (2005). Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development, 132, 1127-1136.
28. Christofori, G. (2006). New signals from the invasive front. Nature, 441, 444-450.
29. Jin, H., Aiyer, A., Su, J., Borgstrom, P., Stupack, D., Friedlander, M., et al. (2006). A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. Journal of Clinical Investigation, 116, 652-662.
30. Song, S., Ewald, A. J., Stallcup, W., Werb, Z., & Bergers, G. (2005). PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nature Cell Biology, 7, 870-879.
31. Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860-867.
32. Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., et al. (2004). Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Medicine, 10, 64-71.
33. Kalluri, R., & Zeisberg, M. (2006). Fibroblasts in cancer. Nature Reviews. Cancer, 6, 392-401.
34. Olaso, E., Salado, C., Egilegor, E., Gutierrez, V., Santisteban, A., Sancho-Bru, P., et al. (2003). Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology, 37, 674-685.
35. Olaso, E., Santisteban, A., Bidaurrazaga, J., Gressner, A. M., Rosenbaum, J., & Vidal-Vanaclocha, F. (1997). Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology, 26, 634-642.
36. Grum-Schwensen, B., Klingelhofer, J., Berg, C. H., El-Naaman, C., Grigorian, M., Lukanidin, E., et al. (2005). Suppression of tumor development and metastasis formation in mice lacking the S100A4 (mts1) gene. Cancer Research, 65, 3772-3780.
37. Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., et al. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biology, 2, E7.
38. Ge, Y., Zhan, F., Barlogie, B., Epstein, J., Shaughnessy, J., Jr., & Yaccoby, S. (2006). Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival. British Journal of Haematology, 133, 83-92.
39. Kelly, T. (2005). Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): Cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resistance Updates, 8, 51-58.
40. Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z., & Damsky, C. H. (1995). Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. Journal of Cell Biology, 129, 867-879.
41. Yakubenko, V. P., Lobb, R. R., Plow, E. F., & Ugarova, T. P. (2000). Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Experimental Cell Research, 260, 73-84.
42. Naumov, G. N., Akslen, L. A., & Folkman, J. (2006). Role of angiogenesis in human tumor dormancy: Animal models of the angiogenic switch. Cell Cycle, Aug. 15, 2006, epub ahead of print.
43. Wu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., et al. (2006). The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. International Journal of Cancer, 119, 1519-1529.
44. Yang, A. D., Camp, E. R., Fan, F., Shen, L., Gray, M. J., Liu, W., et al. (2006). Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Research, 66, 46-51.
45. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., et al. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382, 635-638.
46. Ara, T., Tokoyoda, K., Sugiyama, T., Egawa, T., Kawabata, K., & Nagasawa, T. (2003). Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity, 19, 257-267.
47. Dar, A., Goichberg, P., Shinder, V., Kalinkovich, A., Kollet, O., Netzer, N., et al. (2005). Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nature Immunology, 6, 1038-1046.
48. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
49. Kaifi, J. T., Yekebas, E. F., Schurr, P., Obonyo, D., Wachowiak, R., Busch, P., et al. (2005). Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. Journal of the National Cancer Institute, 97, 1840-1847.
50. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., et al. (2001). A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. Journal of Immunology, 167, 4747-4757.
51. Sun, Y. X., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., et al. (2003). Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. Journal of Cellular Biochemistry, 89, 462-473.
52. Porcile, C., Bajetto, A., Barbero, S., Pirani, P., & Schettini, G. (2004). CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Annals of the New York Academy of Sciences, 1030, 162-169.
53. Sun, Y. X., Schneider, A., Jung, Y., Wang, J., Dai, J., Wang, J., et al. (2005). Skeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. Journal of Bone and Mineral Research, 20, 318-329.
54. Nakamura, E.S., Koizumi, K., Kobayashi, M., Saitoh, Y., Arita, Y., Nakayama, T., et al. (2006). RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clinical & Experimental Metastasis, July 5, 2006, epub ahead of print.
55. Moore, M. A. (2001). The role of chemoattraction in cancer metastases. BioEssays, 23, 674-676.
56. Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Cote, D., Means, T. K., et al. (2005). In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature, 435, 969-973.
57. Asou, Y., Rittling, S. R., Yoshitake, H., Tsuji, K., Shinomiya, K., Nifuji, A., et al. (2001). Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology, 142, 1325-1332.
58. Ek-Rylander, B., Flores, M., Wendel, M., Heinegard, D., & Andersson, G. (1994). Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. Journal of Biological Chemistry, 269, 14853-14856.
59. Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B., Webb, R. J., Denhardt, D. T., et al. (2005). Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106, 1232-1239.
60. Wai, P. Y., & Kuo, P. C. (2004). The role of osteopontin in tumor metastasis. Journal of Surgical Research, 121, 228-241.
61. Kang, Y., Chen, C. R., & Massague, J. (2003). A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Molecular Cell, 11, 915-926.
62. Tuck, A. B., Hota, C., Wilson, S. M., & Chambers, A. F. (2003). Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene, 22, 1198-1205.
63. Braun, S., Pantel, K., Muller, P., Janni, W., Hepp, F., Kentenich, C. R., et al. (2000). Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. New England Journal of Medicine, 342, 525-533.
64. Macadam, R., Sarela, A., Wilson, J., MacLennan, K., & Guillou, P. (2003). Bone marrow micrometastases predict early postoperative recurrence following surgical resection of oesophageal and gastric carcinoma. European Journal of Surgical Oncology, 29, 450-454.
65. Pierga, J. Y., Bonneton, C., Vincent-Salomon, A., de Cremoux, P., Nos, C., Blin, N., et al. (2004). Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clinical Cancer Research, 10, 1392-1400.
66. Nicola, M. H., Bizon, R., Machado, J. J., Sollero, T., Rodarte, R. S., Nobre, J. S., et al. (2003). Breast cancer micrometastases: Different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata. Clinical & Experimental Metastasis, 20, 471-479.
67. Aldridge, S. E., Lennard, T. W., Williams, J. R., & Birch, M. A. (2005). Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. British Journal of Cancer, 92, 1531-1537.
68. Kitagawa, Y., Dai, J., Zhang, J., Keller, J. M., Nor, J., Yao, Z., et al. (2005). Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Research, 65, 10921-10929.
69. Niida, S., Kondo, T., Hiratsuka, S., Hayashi, S., Amizuka, N., Noda, T., et al. (2005). VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 102, 14016-14021.
70. Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423, 337-342.
71. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., et al. (2006). Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nature Medicine, 12, 657-664.
72. Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., et al. (2006). Regulation of cancer cell migration and bone metastasis by RANKL. Nature, 440, 692-696.
73. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., et al. (2005). Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells, 23, 879-894.
74. Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986). Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. Journal of Biological Chemistry, 261, 12665-12674.
75. Scadden, D. T. (2006). The stem-cell niche as an entity of action. Nature, 441, 1075-1079.